Verserc
April 23, 2024Vita Stress Tab
April 23, 2024Vinporal
17.00 EGP
5 mg 20 tablet
Tradename:
Vinporal
Compound:
Each tablet contains:
Vinpocetine 5 mg
Auxiliary components:
Lactose, low molecular weight cellulose, talc, magnesium stearate.
Properties:
A drug that improves cerebral circulation. It has a vasodilating, antihypoxic and antiplatelet effect. The mechanism of action is associated with inhibition of phosphodiesterase, this leads to an increase in the content of cAMP in cells, which, in turn, causes a decrease in the calcium content in the cytoplasm of smooth muscle cells and relaxation of myofibrils.
Improves metabolism in tissues and dilates brain vessels, increases blood flow, mainly in ischemic areas, improves oxygen supply to the brain. Promotes the utilization of glucose and increases the level of catecholamines in the central nervous system, stimulates the metabolism of norepinephrine and serotonin in brain tissue. Reduces platelet aggregation, blood viscosity, increases the deformability of erythrocytes and normalizes venous outflow while reducing cerebral vascular resistance. Systemic blood pressure decreases slightly.
Vinpocetine is effective in the acute period of stroke: it accelerates the regression of general cerebral and focal neurological symptoms, improves memory, attention, and intellectual productivity. In old age and senility, the sensitivity of cerebral vessels to the relaxing effect of vinpocetine increases, which is due to sensitization of the adenylate cyclase-cAMP system during aging.
Indications:
Acute (if parenteral administration is not possible) and chronic forms of cerebral circulatory failure (including acute and residual stages of stroke, transient ischemic attacks, encephalopathy, dementia after cerebrovascular accidents);
vascular diseases of the retina and/or choroid (due to atherosclerosis, vasospasm, thrombosis); degenerative changes in the macula caused by atherosclerosis or vasospasm; secondary glaucoma (due to vascular obstruction);
age-related vascular or toxic (drug-induced) hearing impairment, Meniere’s disease, dizziness of labyrinthine origin;
vegetative manifestations of menopausal syndrome.
Directions for use and dosage:
The drug should be prescribed at a dose of 5-10 mg 3 times a day for 2 months. Before discontinuing the drug, the dose should be gradually reduced.
Repeated courses are possible 2-3 times a year.
Contraindications:
– pronounced heart rhythm disturbances;
-IHD (severe);
-acute stage of hemorrhagic stroke;
-pregnancy;
-lactation (breastfeeding);
– hypersensitivity to the components of the drug.
Precautionary measures:
Vinpocetine is contraindicated for use during pregnancy and lactation (breastfeeding).
Side effects:
From the cardiovascular system: decreased blood pressure, tachycardia, extrasystole, slowed intraventricular conduction.
Storage method:
Store at a temperature not exceeding 30 degrees.
Package:
The cardboard box contains 2 blisters of 10 tablets, paper instructions.